Organization
Robert Fox
2 clinical trials
Clinical trial
A Single-Arm, Single-Site, Single-Dose Phase 1 Study Assessing the Safety of Bryostatin in the Treatment of Patients With Multiple SclerosisStatus: Recruiting, Estimated PCD: 2026-04-01
Clinical trial
Phase 1 Study Evaluating the Safety of [11C]MeDAS Myelin-Targeting PET Agent in HumansStatus: Not yet recruiting, Estimated PCD: 2025-12-01